肝移植后的血栓性并发症:病因学和管理
1Defence Institute of Physiology and Allied Sciences, Defence Research and Development organization, Delhi 110054, India. sri_swati@rediffmail.com.
World journal of critical care medicine
|December 10, 2024
概括
肝移植 (LT) 是一种至关重要的手术,但血栓性并发症存在重大风险. 了解LT患者的血栓形成对于改善存活率和减少捐赠者和接受者的并发症至关重要.
科学领域:
- 移植手术 移植手术
- 血管外科 血管外科
- 肝病学 肝病学是一种肝病学.
背景情况:
- 肝移植 (LT) 为末期肝病提供拯救生命的治疗方法.
- 整形肝移植 (OLT) 患者面临各种术后并发症的风险,包括血管问题.
- 动脉和静脉血栓并发症在OLT后很常见,增加了发病率和死亡率.
研究的目的:
- 审查目前关于LT后血管并发症的知识.
- 突出这些并发症对患者和移植结果的影响.
- 为了确定了解LT患者血栓形成的风险因素的差距.
主要方法:
- 在肝移植中血管并发症的文献综述.
- 在OLT后对血栓事件 (动脉和静脉) 的分析.
- 讨论有关风险因素和预防的现有数据.
主要成果:
- 血管并发症,特别是血栓形成,显著影响LT后的短期和长期结果.
- 对于LT患者来说,缺乏标准化的血栓预防方案,与一般手术不同.
- 静血失衡导致移植损失,发病率和死亡率.
结论:
- 了解LT中血栓形成的病理生理学对于及时诊断和管理至关重要.
- 解决有关血栓形成风险因素的知识缺口至关重要.
- 需要改进的策略来减轻血栓风险,并提高肝移植患者的治疗结果.
更多相关视频
05:25Author Spotlight: Exploring Cold Ischemia and Warm Reperfusion Injury in Fatty Liver Transplantation
Published on: December 1, 2023
1.3K
04:00Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension
Published on: November 15, 2024
154
相关概念视频
Esophageal Varices-II: Clinical Features and Management
46
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
46
Anticoagulant Drugs: Low-Molecular-Weight Heparins
616
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
616
Esophageal Varices-I: Introduction
73
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
73
Disorders of Hemostasis
707
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
707
Tissue Transplantation
338
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
338
